## Variants and diseases

### Relational list using [ClinVar](https://www.ncbi.nlm.nih.gov/clinvar/)

|Disease|Disease description|Gene|Variantsï¼ˆHGVS)|
|-------|-------------------|----|--------|
|Hemochromatosis|a disorder that causes the body to absorb too much iron from the diet|HJV|NM_213653.4:c.187C>T|
|Thalassemia|	inherited blood disorders that result in abnormal hemoglobin	|	ATRX	|	NM_000489.6:c.6253C>T 	|
|Haemophilia|	 inherited bleeding disorder in which the blood does not clot properly characterized by deficiency in factor VIII clotting activity | F8 |NM_000132.4:c.4936del 	|
|Cystic Fibrosis|	 inherited condition that causes sticky mucus to build up in the lungs and digestive system. 	|	CFTR	|NM_000492.4:c.3623del 		|
|Tay sachs disease|	genetic disorder that results in the destruction of nerve cells in the brain and spinal cord	|	HEXA	|	NM_000520.6:c.1385A>T	|
|Fragile X syndrome|	genetic condition that causes a range of developmental problems including learning disabilities and cognitive impairment	|	COL1A1	|	NM_000088.4:c.934C>T|
|Huntington's disease|	condition that damages nerve cells in the brain causing them to stop working properly	|	PRNP	|	NM_000311.5:c.593T>C 	|


### Relational list using [ClinGen](https://clinicalgenome.org/)

|Gene|Gene name|Chromosomal location|Gene product|Disease|Disease description|
|----|---------|--------------------|------------|-------|-------------------|
|CFTR|CF transmembrane conductance regulator|7q31.2|epithelial ion channel, transport of chloride ions across the cell membrane|Cystic fibrosis|a genetic disorder characterized by the production of sweat with a high salt content and mucus secretions with an abnormal viscosity|		 |
|CYBB|	cytochrome b-245 beta chain	    |	Xp21.1-p11.4	| terminal component of a respiratory chain of the membrane-bound oxidase of phagocytes that generates superoxide		|	Granulomatous disease	|		genetic disorder in which phagocytes are unable to kill certain types of bacteria and fungi |
|HJV|		hemojuvelin BMP co-receptor  |	1q21.1	|	bone morphogenetic protein (BMP) coreceptor, enhances BMP signaling, regulates hepcidin (HAMP) expression and regulates iron homeostasis  	|	Hemochromatosis type 2A	|		disease characterized by onset of severe iron overload occurring typically in the first to third decades of life |
|CDKN2A|	cyclin dependent kinase inhibitor 2A|	9p21.3	|	negative regulator of the proliferation of normal cells by interacting strongly with CDK4 and CDK6	|	Melanoma-pancreatic cancer syndrome	|	herited cancer predisposition syndrome in which mutation carriers have an increased risk of developing malignant melanoma and/or pancreatic cancer |
|KRAS|	KRAS proto-oncogene   |	12p12.1	|	Ras proteins bind GDP/GTP and possess intrinsic GTPase activity, important role in the regulation of cell proliferation 	|	Noonan syndrome |		genetic condition that stops typical development in various parts of the body |
|TP53|	  tumor protein p53  	|	17p13.1	|		tumor suppressor in many tumor types, induces growth arrest or apoptosis |	Li-Fraumeni syndrome 1	|		disorder that greatly increases the risk of developing several types of cancer |
|	COL1A1 |		collagen type I alpha 1 chain    |	17q21.33	|	Type I collagen is a member of group I collagen (fibrillar forming collagen)	|Fragile X syndrome|a genetic disorder characterized by mild-to-moderate intellectual disability|


